Lana Kandalaft
Tumor immunology


Undergraduate, University of Jordan, Jordan

Masters, University of Pennsylvania, USA

Doctorate and PhD, University of Cardiff, UK

I am currently the associate director of clinical translation at the Lausanne Branch.  The work of my group focuses on the clinical development of personalized cancer vaccines. Our aim is to enhance whole tumor lysate vaccination approaches and other personalized cancer vaccine approaches by improving the dendritic cell platform and by choosing the most immunogenic antigen with the most practical preparation to be translated rapidly to the clinic. The other focus of the lab is to find the best setting to integrate vaccines in the standard of care treatment plan for ovarian cancer patients and to understand the immune fitness of cancer patients and correlate it with vaccination.

Ludwig Institute for Cancer Research, Lausanne
Agora Research Center
Rue du Bugnon 25A, CH-1005 Lausanne

T (41) 21 545 10 77
F (41) 21 692 59 95


You are now leaving Ludwig Cancer Research's website and are going to a website that is not operated by the association. We are not responsible for the content or availability of linked sites. Do you wish to continue?